Borgeat A
Department of Orthopaedics, Klinik Balgrist, University of Zurich, Switzerland.
Eur J Anaesthesiol Suppl. 1997 May;15:17-20. doi: 10.1097/00003643-199705001-00004.
The pro- or anticonvulsant properties of propofol remain a matter of controversy. Although numerous case reports describe the appearance of abnormal movements, posturing and seizure-like activity related to the use of propofol, systematic studies in both humans and animals strongly suggest that it possesses antiepileptic properties. Propofol consistently reduces the seizure duration during electroconvulsive therapy, its use has been successful in controlling refractory status epilepticus and in animals it offers a strong protection against lignocaine- or pentylene-tetrazol-induced epilepsy. The beneficial effects of propofol may be related to its uniform depressant action on the central nervous system, to a potentialization of GABA-mediated pre- and postsynaptic inhibition, and by decreasing the release of excitatory transmitters, glutamate and aspartate.
丙泊酚的促惊厥或抗惊厥特性仍存在争议。尽管众多病例报告描述了与丙泊酚使用相关的异常运动、姿势及癫痫样活动的出现,但在人类和动物身上进行的系统研究有力地表明它具有抗癫痫特性。丙泊酚在电惊厥治疗期间持续缩短癫痫发作持续时间,其使用已成功控制难治性癫痫持续状态,并且在动物实验中它能有效预防利多卡因或戊四氮诱发的癫痫。丙泊酚的有益作用可能与其对中枢神经系统的均匀抑制作用、增强GABA介导的突触前和突触后抑制以及减少兴奋性递质谷氨酸和天冬氨酸的释放有关。